APA (7th ed.) Citation

Shah, N. N., Merchant, M. S., Cole, D. E., Jayaprakash, N., Bernstein, D., Delbrook, C., . . . Wayne, A. S. (2016). Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. Pediatric blood & cancer, 63(6), 997-1005. https://doi.org/10.1002/pbc.25937

Chicago Style (17th ed.) Citation

Shah, Nirali N., Melinda S. Merchant, Diane E. Cole, Nalini Jayaprakash, Donna Bernstein, Cindy Delbrook, Kelly Richards, Brigitte C. Widemann, and Alan S. Wayne. "Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias." Pediatric Blood & Cancer 63, no. 6 (2016): 997-1005. https://doi.org/10.1002/pbc.25937.

MLA (9th ed.) Citation

Shah, Nirali N., et al. "Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias." Pediatric Blood & Cancer, vol. 63, no. 6, 2016, pp. 997-1005, https://doi.org/10.1002/pbc.25937.